First Time Loading...

Editas Medicine Inc
NASDAQ:EDIT

Watchlist Manager
Editas Medicine Inc Logo
Editas Medicine Inc
NASDAQ:EDIT
Watchlist
Price: 5.208 USD -2.65% Market Closed
Updated: Apr 25, 2024

ROCE
Return on Capital Employed

-38%
Current
-35%
Average
-30.5%
Industry
Negative for the last year
-38%
Negative average
-35%
Worse than average
Worse than industry value

ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.

ROCE
-38%
=
EBIT
-169.2m
/
Capital Employed
421.4m

ROCE Across Competitors

ROCE Comparison
Editas Medicine Inc Competitors

Country Company Market Cap ROCE
US
Editas Medicine Inc
NASDAQ:EDIT
425.8m USD
-38%
US
Abbvie Inc
NYSE:ABBV
295.7B USD
16%
US
Amgen Inc
NASDAQ:AMGN
143.7B USD
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.5B USD
22%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
97.6B USD
15%
AU
CSL Ltd
ASX:CSL
134.5B AUD
11%
US
Gilead Sciences Inc
NASDAQ:GILD
81.5B USD
18%
US
Seagen Inc
NASDAQ:SGEN
43.1B USD
-27%
US
Moderna Inc
NASDAQ:MRNA
40.1B USD
-23%
US
Biogen Inc
NASDAQ:BIIB
28.9B USD
9%
KR
Celltrion Inc
KRX:068270
36.8T KRW
6%
Editas Medicine Inc
NASDAQ:EDIT
Country US
Market Cap 425.8m USD
ROCE
-38%
Abbvie Inc
NYSE:ABBV
Country US
Market Cap 295.7B USD
ROCE
16%
Amgen Inc
NASDAQ:AMGN
Country US
Market Cap 143.7B USD
ROCE
13%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Country US
Market Cap 102.5B USD
ROCE
22%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Country US
Market Cap 97.6B USD
ROCE
15%
CSL Ltd
ASX:CSL
Country AU
Market Cap 134.5B AUD
ROCE
11%
Gilead Sciences Inc
NASDAQ:GILD
Country US
Market Cap 81.5B USD
ROCE
18%
Seagen Inc
NASDAQ:SGEN
Country US
Market Cap 43.1B USD
ROCE
-27%
Moderna Inc
NASDAQ:MRNA
Country US
Market Cap 40.1B USD
ROCE
-23%
Biogen Inc
NASDAQ:BIIB
Country US
Market Cap 28.9B USD
ROCE
9%
Celltrion Inc
KRX:068270
Country KR
Market Cap 36.8T KRW
ROCE
6%

Profitability Report

View the profitability report to see the full profitability analysis for Editas Medicine Inc.

Full Profitability Report

See Also

Summary
EDIT intrinsic value, competitors valuation, and company profile.
DCF Valuation
EDIT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EDIT stock valuation using valuation multiples.
Wall Street Estimates
EDIT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EDIT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Return on Capital Employed?

ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.

ROCE
-38%
=
EBIT
-169.2m
/
Capital Employed
421.4m
What is the ROCE of Editas Medicine Inc?

Based on Editas Medicine Inc's most recent financial statements, the company has ROCE of -38%.

ALPHA SPREAD
Join more than 131,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.